強力なユーザー共有プラットフォーム

もちろん、個人的な学習効果は特に目立ちません。なぜなら、この問題を解決するために、テストの難点、良いアップデートを同時に得られないという最新の試験の傾向を掴むのは難しいからです。 圧倒的多数のユーザーのためのOGEA-102研究問題集は、ユーザーが共有するための強力なプラットフォームを提供します。 ここでは、OGEA-102試験問題のすべてのユーザが自分のID番号を通してプラットフォームと他のユーザにログオンして共有し交換することができ、プラットフォーム上でさらに仲良くなるために多くの人々と努力することができます。 他の、学習や生活の中で彼らの困難を解決するためにお互い。OGEA-102準備ガイドは、学習環境だけでなく、家庭のような学習環境を作成することもできます。

便利なPDFダウンロードモード

ユーザーのオフラインでの読解を容易にするために、OGEA-102学習問題集は、特にユーザー向けのPDFモードを開発するために、破片の時間を学習に使用することができます。 このモードでは、ユーザーはダウンロードして印刷すること、紙にメモを取ることが簡単であること、および自分の記憶の弱いリンクを学ぶために、教材内のOGEA-102準備ガイドを知ることができます。 我々のOGEA-102試験問題とユーザの効率を非常に改善します。 あるいは、いわゆる「いい」を忘れてしまうかもしれませんが、今ではオンラインで読むのに便利なあらゆる種類のデジタル機器ですが、私たちの多くは、彼らの記憶パターンを深めるために書面で使われています。 私たちのOGEA-102準備ガイドは、この点でユーザーの需要を満たすのに非常に良いものです。ユーザーが良い環境で読み書きできるようにすることで、学んだことを継続的に統合することができます。

私たちのOGEA-102研究の問題集は、この点でユーザの要求を満たすのに非常に役立ちます。OGEA-102準備ガイドは高品質です。 それでテストの準備をするためのすべての効果的な中心的な習慣があります。 私たちの職業的能力により、OGEA-102試験問題を編集するのに必要なテストポイントに同意することができます。 それはあなたの難しさを解決するための試験の中心を指しています。 だから高品質の材料はあなたが効果的にあなたの試験に合格し、目標を達成するために簡単に感じるようにすることができます。

デモをダウンロードする

さまざまな記憶方法

毎日新しい知識を学んでいるだけでなく、常に忘れられていた知識も私たちは記憶と鍛造の過程にあったと言うことができます。 これには優れたメモリアプローチが必要です、そしてOGEA-102研究の脳ダンプはそれを上手く行います。OGEA-102準備ガイドは、テキスト、画像、グラフィックメモリ方式などの多様化を採用し、情報を学ぶためにマークアップを区別する必要があります。 全体的なレイアウト、目標とされた長期記憶の形成へのより良い手がかり、そして実践のサイクルを通して、知識をより深く私の頭の中に印刷させてください。OGEA-102試験問題は非常に科学的かつ妥当であり、あなたは簡単にすべてを覚えることができます。

The Open Group TOGAF Enterprise Architecture Part 2 認定 OGEA-102 試験問題:

1. Please read this scenario prior to answering the question
You are working as an Enterprise Architect within a healthcare and life science company. The company is a leading player in its industry, dedicated to transforming healthcare with new ideas and advancements. The company has multiple divisions that cover different aspects of the business.
The company's Enterprise Architecture (EA) department has been operating for several years and has mature, well-developed architecture governance and development processes following the TOGAF Standard. In addition to the EA program, the company has a number of management frameworks in use.
The Architecture Board includes representatives from each division of the company.
Many of the company's rivals have begun utilizing Artificial Intelligence (Al) in their operations, and the indications are that this will be transformative for healthcare delivery. This is something the EA department has been interested in for a while, and they had recently submitted an architecture Change Request which was approved. As a result, the CIO has approved a Request for Architecture Work to investigate the implementation of Al in the company.
Areas for evaluation include:
How can staff use Al daily in their current role?
How Al can enhance access to care for patients, and how to make that experience seamless?
How Al can offer new workplace platforms and tools to increase efficiency?
Some of the top managers are worried about a change in the way of working, and if it will achieve the goals.
Many are not confident that the company's risk management processes are adequate for a company-wide integration of generative Al. There are also questions from staff about whether enough specific guidelines and polices have been put in place for responsible use of Al.
The Chief Information Officer (CIO) is the sponsor of the Enterprise Architecture program. The CIO has actively encouraged architecting with agility within the EA department as her preferred approach for projects.
The CIO wants to know how to address these concerns and reduce risks.
Refer to the scenario
You have been tasked with starting the architecture development. How do you begin?
Based on the TOGAF standard which of the following is the best answer?

A) You recommend that an analysis of the stakeholders is undertaken. This will allow the architects to define groups of partners (the stakeholders) who have common concerns and include development of a Stakeholder Map. The concerns and relevant views should then be defined for each group and recorded in the Architecture Vision document. To mitigate risk, you include a requirement that there be progressive development of the target architecture to ensure there is regular feedback.
B) You recommend that a Communications Plan be created to address the key stakeholders, that is the most powerful and influential partners. This plan should include a report that summarizes the key features of the architecture with respect to each location and reflects the stakeholders' requirements.
You will check with each key stakeholder that their concerns are being addressed. Risk mitigation should be explicitly addressed as a component of the architecture being developed.
C) You recommend that models be created for the Draft Business, Data, Application, and Technology Architectures. These can be used to ensure that the system will be compliant with the local regulations for each division. Together with the problem description, and requirements, this ensures that all the necessary data and detail is addressed. A formal review should be held with the stakeholders to verify that their concerns have been properly addressed by the models.
D) You recommend creation of a set of business models that can be applied uniformly across all Al- related architecture projects. These should be developed in the portable format to ensure maximum portability across the many tools used in the firm. Each architecture should then be defined based on this fixed set of models. All concerned parties can then examine the models to ensure that their needs have been addressed.

2. Please read this scenario prior to answering the question
You are serving as the Lead Architect for an Enterprise Architecture team within a leading multinational biotechnology company. The company works in three major industries, including healthcare, crop production, and agriculture. Your team works within the healthcare division.
The healthcare division is developing a new vaccine, and has to demonstrate its effectiveness and safety in a set of clinical trials that satisfy the regulatory requirements of the relevant health authorities. The clinical trials are undertaken by its research laboratories at multiple facilities worldwide. In addition to internal research and development activities, the healthcare division is also involved in publicly funded collaborative research projects with industrial and academic partners.
The Enterprise Architecture team has been engaged in an architecture project to develop a secure system that will allow the healthcare researchers to share information more easily about their clinical trials, and work more collaboratively across the organization and also with its partners. This system will also connect with external partners.
The Enterprise Architecture team uses the TOGAF ADM with extensions required to support healthcare manufacturing practices and laboratory practices. Due to the highly sensitive nature of the information that is managed, special care has been taken to ensure that each architecture domain considers the security and privacy issues that are relevant.
The Vice President for Worldwide Clinical Research is the sponsor of the Enterprise Architecture activity. She has stated that disruptions must be minimized for the clinical trials, and that the rollout must be undertaken incrementally.
Refer to the scenario
You have been asked to recommend the approach to identify the work packages for an incremental rollout meeting the requirements.
Based on the TOGAF standard which of the following is the best answer?

A) You recommend that the Solution Building Blocks from a Consolidated Gaps, Solutions and Dependencies Matrix be grouped into a set of work packages. Using the matrix as a planning tool, regroup the work packages to account for dependencies. Sequence the work packages into the Capability Increments needed to achieve the Target Architecture, so that the implementation team can schedule the rollout one region at a time to minimize disruption. Document the work packages for the Enterprise Architecture using a Transition Architecture State Evolution Table.
B) You recommend that the set of required Solution Building Blocks be determined by identifying those which need to be developed and which need to be procured. Eliminate any duplicates. Group the remaining Solution Building Blocks together to create the work packages using a CRUD (create, read, update, delete) matrix. Rank the work packages and select the most cost-effective options for inclusion in a series of Transition Architectures. Schedule the roll out of the work packages to be sequential across the geographic regions.
C) You recommend that a Consolidated Gaps. Solutions and Dependencies Matrix is used as a planning tool for creating work packages. For each gap classify whether the solution is either a new development, purchased solution, or based on an existing product. Group the similar solutions together to define the work packages. Regroup the work packages into a set of Capability Increments to transition to the Target Architecture considering the schedule for clinical trials, and document in an Architecture Definition Increments Table.
D) You recommend that an Implementation Factor Catalog is drawn up to indicate actions and constraints. A Consolidated Gaps. Solutions and Dependencies Matrix should also be created. For each gap. identify a proposed solution and classify it as new development, purchased solution, or based on an existing product. Group similar activities together to form work packages. Identify dependencies between work packages factoring in the clinical trial schedules. Regroup the work packages into a set of Capability Increments scheduled into a series of Transition Architectures.

質問と回答：